OnKure Therapeutics, Inc. OKUR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s retained earnings?
- OnKure Therapeutics, Inc. (OKUR) reported retained earnings of -$229.4M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s retained earnings changed year-over-year?
- OnKure Therapeutics, Inc.'s retained earnings decreased by 34.4% year-over-year, from -$170.65M to -$229.4M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s retained earnings has grown at a 36.7% compound annual growth rate (CAGR), from -$44.96M to -$214.24M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.